SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: Steve Fancy who wrote (5958)1/26/1999 5:14:00 PM
From: mod  Read Replies (2) | Respond to of 6136
 
If it excluded oncology, they would have said so in the press release.

I am disappointed with AGPH, as I thought they were worth $60 on their own. Any takeover should have been at a 20-30% premium, not zero (or negative if you factor in the time discount). I don't want to own WLA, so I'll sell tomorrow. I would guess AGPH will probably trade around $55.